Johannes Gutenberg University Mainz
uni-mainz.deTotal trials
155
Active
16
Phase 3
4
Total enrollment
42,810
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Airway Morbidity7
- Coronary Artery Disease5
- Hepatocellular Carcinoma3
- Pediatric Oncology3
- Airway Management3
- Cancer3
- Diabetes Mellitus, Type 22
- Atrial Fibrillation2
Frequently asked questions about Johannes Gutenberg University Mainz
- How many clinical trials does Johannes Gutenberg University Mainz have on ClinicalTrials.gov?
- Johannes Gutenberg University Mainz is listed as the lead sponsor on 155 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Johannes Gutenberg University Mainz's trials are in Phase 3?
- 4 of Johannes Gutenberg University Mainz's trials are in Phase 3.
- What therapeutic areas does Johannes Gutenberg University Mainz focus on?
- Johannes Gutenberg University Mainz's most-studied conditions on ClinicalTrials.gov are Airway Morbidity, Coronary Artery Disease, Hepatocellular Carcinoma, Pediatric Oncology, Airway Management.